PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP

(19)

(11)

EP 1 467 997 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	27.08.2008 Bulletin 2008/35

(45)	Mention of the grant of the patent:
	26.03.2008 Bulletin 2008/13

(21)	Application number: 03768186.3

(22)	Date of filing: 24.12.2003

(51)

International Patent Classification (IPC):

C07D 487/04^(2006.01)
A61K 31/439^(2006.01)
A61P 25/00^(2006.01)
C07F 9/6561^(2006.01)

A61K 31/4375^(2006.01)
A61K 31/519^(2006.01)
C07D 471/04^(2006.01)
C07D 519/00^(2006.01)

(86)	International application number:
	PCT/JP2003/016598

(87)	International publication number:
	WO 2004/058767 (15.07.2004 Gazette 2004/29)

(54)	PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES SUBSTITUTED WITH CYCLIC AMINO GROUP AMINOCYCLISCHE SUBSTITUIERTE PYRROLOPYRIMIDINDERIVATE UND PYRROLOPYRIDINDERIVATE DERIVES DE PYRROLOPYRIMIDINE ET DE PYRROLOPYRIDINE A SUBSTITUTION PAR UN GROUPE AMINO CYCLIQUE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

26.12.2002 JP 2002383667

(43)	Date of publication of application:
	20.10.2004 Bulletin 2004/43

(60)	Divisional application:
	06019987.4 / 1787992

(73)	Proprietor: Taisho Pharmaceutical Co. Ltd.
	Tokyo 170-8633 (JP)

(72)

Inventors:

NAKAZATO, Atsuro, TAISHO PHARMACEUTICAL CO., LTD.
Tokyo 170-8633 (JP)
OKUBO, Taketoshi, TAISHO PHARMACEUTICAL CO., LTD.
Tokyo 170-8633 (JP)
NOZAWA, Dai, TAISHO PHARMACEUTICAL CO., LTD.
Tokyo 170-8633 (JP)
YAMAGUCHI, Mikako, TAISHO PHARMACEUTICAL CO., LTD.
Tokyo 170-8633 (JP)
TAMITA, Tomoko, TAISHO PHARMACEUTICAL CO., LTD.
Tokyo 170-8633 (JP)
KENNIS, Ludo E.J.
2340 Beerse (BE)
DE BRUYN, Marcel F. L.
2340 Beerse (BE)
BONGARTZ, Jean-Pierre A. M.
2340 Beerse (BE)
VAN DEN KEYBUS, Frans M. A.
2340 Beerse (BE)
VAN ROOSBROECK, Yves E. M.
2340 Beerse (BE)
LUYCKX, Marcel G. M.
2340 Beerse (BE)
HENDRICKX, Robert J. M.
2340 Beerse (BE)

(74)	Representative: HOFFMANN EITLE
	Patent- und Rechtsanwälte Arabellastrasse 4 81925 München 81925 München (DE)

(56)

References cited: :

WO-A-02/02549

HSIN, LING-WEI ET AL: "CRHR1 Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists" BIOORGANIC & MEDICINAL CHEMISTRY (2001), VOLUME DATE 2002, 10(1), 175-183 , XP002275670 cited in the application


	Remarks:
	The file contains technical information submitted after the application was filed and not included in this specification

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).